Skip to main content

and
  1. Article

    Open Access

    Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer

    Bevacizumab (Bev) plus chemotherapy is a standard first-line treatment in metastatic colorectal cancer (mCRC), however to date no predictive factors of response have been identified. Results of our previous an...

    Giorgia Marisi, Irene Azzali, Alessandro Passardi, Francesca Rebuzzi in Scientific Reports (2023)